Riskpilot← Back to searchSign inGet full accessMØRE HELSE AS
ASActiveOrg 926281135Bjørndalvegen 7, 6065 UlsteinvikTraditional, complementary and alternative medicine activities · NACE 8696Est. 20201 employeeswww.nvnk.no
Revenue 2025
NOK 2,3M
+15% vs 2024
EBITDA margin
6.0%
-4% vs 2024
Equity ratio
18.2%
Financial strength
Net profit 2025
NOK 65K
-16% vs 2024
| Revenue | NOK 2,3M | +15% |
| EBITDA | NOK 139K | -4% |
| Net profit | NOK 65K | -16% |
| Total assets | NOK 497K | +1% |
| Equity | NOK 90K | -36% |
| Employees | 1 | — |
Legal name
MØRE HELSE AS
Org number
926281135
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
21. desember 2020
Share capital
NOK 60 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Naprapati, øvrig behandling og rehabilitering, investering i andre selskap og annet som naturlig faller sammen med dette.
Address
Bjørndalvegen 7, 6065 Ulsteinvik
Phone
+4771120000
Email
postmottak@helse-mr.no
Website
www.nvnk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 242 | 2 328 | 2 206 | 2 016 | 2 309 |
| Staff expenses | −1 412 | −1 626 | −1 369 | −1 002 | −1 082 |
| EBITDA | 154 | 125 | 170 | 145 | 139 |
| Depreciation & amort. | −64 | −73 | −69 | −45 | −45 |
| EBIT | 90 | 52 | 100 | 99 | 94 |
| Net financials | −17 | −14 | 24 | 0 | −0 |
| Profit before tax | 72 | 38 | 124 | 100 | 93 |
| Tax | 17 | 13 | 24 | 22 | 28 |
| Net profit | 55 | 25 | 100 | 78 | 65 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 970 | 959 | 525 | 491 | 497 |
| Equity | 350 | 374 | 151 | 141 | 90 |
| Long-term debt | 256 | 150 | 0 | 0 | 0 |
| Short-term debt | 364 | 435 | 374 | 350 | 407 |
| Total debt | 620 | 585 | 374 | 350 | 407 |
EBITDA margin
6.0%
This company
15.8%
Market median
-62% vs market
20212025
Equity ratio
18.2%
This company
38.2%
Market median
-52% vs market
20212025
Return on equity
72.4%
This company
18.4%
Market median
+293% vs market
20212025
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20212025
Asset turnover
4.64×
This company
1.12×
Market median
+314% vs market
20212025
Debt / equity
4.50×
This company
0.62×
Market median
-626% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-12-07 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SL Chief Executive Officer | Chief Executive Officer | 2024 |
EM Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
OT Chief Executive Officer | Chief Executive Officer | 2020 – 2023 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 66.67% | 66.67% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Solkanten As
MØRE HELSE AS Board members of MØRE HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Lande Rise | Chief Executive Officer | 0 companies |
| Eva Marie Lande Rise | Chief Executive Officer | 0 companies |
| Ole Theodor Hovden | Chief Executive Officer | 0 companies |